Not applicableStudy completedNCT01160705What this trial is testingBiomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2Who this might be right forMetastatic CancerProstate Cancer Cancer Trials Ireland 73
Testing effectiveness (Phase 2)Study completedNCT03101046What this trial is testingTreatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells KineticWho this might be right forProstate CarcinomaCastration-resistant Prostate CancerCirculating Tumor Cells+1 more UNICANCER 40
Testing effectiveness (Phase 2)Study completedNCT01091103What this trial is testingDetermine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of EnzalutamideWho this might be right forMetastatic Progressive Castration-resistant Prostate Cancer Pfizer 60
Large-scale testing (Phase 3)UnknownNCT02394496What this trial is testingOvercoming Endocrine Resistance in Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Consorzio Oncotech 396
Testing effectiveness (Phase 2)Ended earlyNCT05917470What this trial is testingA Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.Who this might be right forMetastatic Castration-resistant Prostate Cancer Oncternal Therapeutics, Inc 21
Early research (Phase 1)Study completedNCT06377683What this trial is testingClinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate CancerWho this might be right forMetastatic Castration-resistant Prostate Cancer, mCRPC The First Affiliated Hospital of Xiamen University 8
Not applicableActive Not RecruitingNCT05925569What this trial is testingElectronic Alert to Improve Testing For Primary Aldosteronism in Patients With HypertensionWho this might be right forPrimary AldosteronismResistant HypertensionSecondary Hypertension+3 more Brigham and Women's Hospital 12,501
Large-scale testing (Phase 3)Looking for participantsNCT06629779What this trial is testingLearn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Who this might be right forMetastatic Castration-Resistant Prostate Cancer Pfizer 900
Large-scale testing (Phase 3)Study completedNCT00924989What this trial is testingOSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaWho this might be right forAdrenocortical Carcinoma Astellas Pharma Inc 139
Testing effectiveness (Phase 2)Ended earlyNCT00470249What this trial is testingCarboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer University of Southampton 5
Early research (Phase 1)Ended earlyNCT03054038What this trial is testingAfatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Carcinoma Vanderbilt-Ingram Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT02346526What this trial is testingA Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate CancerWho this might be right forProstate CancerCastration-resistant Prostate CancerCastration-resistant Prostate Cancer Metastatic to Bone Massachusetts General Hospital 22
Testing effectiveness (Phase 2)Ended earlyNCT02204332What this trial is testingPhase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard TreatmentWho this might be right forColorectal Cancer Hospital Clinico Universitario de Santiago 38
Large-scale testing (Phase 3)Looking for participantsNCT06585007What this trial is testingMetastasis-directed Therapy in Oligoprogressive Castration-refractory Prostate CancerWho this might be right forCastration-resistant Prostate CancerOligoprogressive Universitaire Ziekenhuizen KU Leuven 246
Testing effectiveness (Phase 2)Study completedNCT03007992What this trial is testingMetronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast CancerWho this might be right forMetastatic Breast Cancer Johannes Gutenberg University Mainz 9
Testing effectiveness (Phase 2)Ended earlyNCT04458311What this trial is testingAbiraterone Acetate in Combination With TildrakizumabWho this might be right forMetastatic Castration Resistant Prostate Cancer Institute of Cancer Research, United Kingdom 13
Early research (Phase 1)UnknownNCT04323475What this trial is testingPhage Therapy for the Prevention and Treatment of Wound Infections in Burned PatientsWho this might be right forWound Infection Precisio Biotix Therapeutics, Inc. 12
Not applicableWithdrawnNCT02772575What this trial is testingSee if we Can Predict How Your Liver Tumor or Liver Metastases Will Respond to Trans-Arterial Embolization (TAE)Who this might be right forLiver CancerLiver Metastases Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT03574571What this trial is testingTest Radium-223 With Docetaxel in Patients With Prostate CancerWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 732
Testing effectiveness (Phase 2)WithdrawnNCT02793765What this trial is testingDocetaxel Followed by Provenge in Metastatic Prostate CancerWho this might be right forProstate Cancer The University of Texas Health Science Center, Houston